These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15946911)

  • 1. Effect of HMG-CoA-reductase inhibitors on survival in type 2 diabetes patients with end stage diabetic nephropathy.
    Götz AK; Böger CA; Hirschmann C; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):155-60. PubMed ID: 15946911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.
    Götz AK; Böger CA; Popal M; Banas B; Krämer BK
    Nephron Clin Pract; 2008; 109(3):c154-60. PubMed ID: 18663328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
    J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival.
    Leeper NJ; Ardehali R; deGoma EM; Heidenreich PA
    Circulation; 2007 Aug; 116(6):613-8. PubMed ID: 17664373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
    Böger CA; Stubanus M; Haak T; Götz AK; Christ J; Hoffmann U; Riegger GA; Krämer BK
    Nephrol Dial Transplant; 2007 Jan; 22(1):154-62. PubMed ID: 17005529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
    Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
    Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
    Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do statins delay the incidence of ESRD in diabetic patients with moderate CKD?
    Conley J; Olafsson A; Djamali A
    J Nephrol; 2010; 23(3):321-7. PubMed ID: 20301084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.
    Shepherd J; Barter P; Carmena R; Deedwania P; Fruchart JC; Haffner S; Hsia J; Breazna A; LaRosa J; Grundy S; Waters D
    Diabetes Care; 2006 Jun; 29(6):1220-6. PubMed ID: 16731999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival of type 2 diabetic patients on renal replacement therapy in Finland.
    Kervinen M; Lehto S; Ikäheimo R; Karhapää P; Grönhagen-Riska C; Finne P
    Nephrol Dial Transplant; 2010 Mar; 25(3):892-6. PubMed ID: 19846391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
    May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
    Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction.
    Al-Mallah MH; Hatahet H; Cavalcante JL; Khanal S
    Cardiol J; 2009; 16(3):227-33. PubMed ID: 19437396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
    Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
    Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease.
    Feringa HH; Karagiannis SE; van Waning VH; Boersma E; Schouten O; Bax JJ; Poldermans D
    J Vasc Surg; 2007 May; 45(5):936-43. PubMed ID: 17360142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.